Abstract
Tobias Rainer, Andreas Adler, Sarina Schaller, Maxi Rosa Kristina Roos, Saban Oezipek, Juergen Fichtl, Tobias Graf, Joanna Houska, Lea Bonnington, Ingo Lindner
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
unpaywall
Confidence 95%
doaj
Confidence 92%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Acetonitrile market size, share, growth, and industry analysis, by type (purity: More than 99.9%,purity: more than 99.5%,other purity), by application (pharmaceutical,laboratory preparation,agrochemical,others), regional insights and forecast to 2033
2025
Potential of green solvents as mobile phases in liquid chromatography
10.1016/j.chroma.2025.465810 · 2025
Liquid chromatography–its development and key role in life science applications
10.1002/anie.200906976 · 2010
Recent advances in chromatography for pharmaceutical analysis
10.1021/acs.analchem.8b05026 · 2019
What is the role of current mass spectrometry in pharmaceutical analysis?
2023
New developments and possibilities of wide-pore superficially porous particle technology applied for the liquid chromatographic analysis of therapeutic proteins
10.1016/j.jpba.2018.06.006 · 2018
A comprehensive strategy for the identification of biologics by liquid-chromatography-mass spectrometry for release testing in a regulated environment
10.1016/j.jpba.2023.115580 · 2023
Chromatographic, electrophoretic, and mass spectrometric methods for the analytical characterization of protein biopharmaceuticals
10.1021/acs.analchem.5b04561 · 2016
Separation of antibody drug conjugate species by RPLC: a generic method development approach
10.1016/j.jpba.2017.01.013 · 2017
Utility of a high coverage phenyl-bonding and wide-pore superficially porous particle for the analysis of monoclonal antibodies and related products
10.1016/j.chroma.2018.03.043 · 2018
Qualitative and quantitative characterization of protein biotherapeutics with liquid chromatography mass spectrometry
10.1002/mas.21500 · 2017
RP-HPLC DAR characterization of site-specific antibody drug conjugates produced in a cell-free expression system
10.1021/acs.oprd.6b00072 · 2016
Characterization of therapeutic oligonucleotides by liquid chromatography
10.1016/j.jpba.2020.113105 · 2020
Review on sample preparation methods for oligonucleotides analysis by liquid chromatography
10.1016/j.jchromb.2018.05.025 · 2018
Analysis and purification of synthetic oligonucleotides by reversed-phase high-performance liquid chromatography with photodiode array and mass spectrometry detection
10.1006/abio.2001.5386 · 2001
Characterization of ring-opening reaction of succinimide linkers in ADCs
10.1016/j.xphs.2018.10.063 · 2019
Direct Liquid Chromatography/Mass Spectrometry Analysis for Complete Characterization of Recombinant Adeno-Associated Virus Capsid Proteins
10.1089/hgtb.2016.178 · 2017
Fast and high-throughput LC-MS characterization, and peptide mapping of engineered AAV capsids using LC-MS/MS
10.1016/j.omtm.2022.09.008 · 2022
A novel protocol for in-depth analysis of recombinant adeno-associated virus capsid proteins using UHPLC-MS/MS
10.1002/rcm.9247 · 2022
The Crucial Step in Every Analytical Workflow: Sample Preparation-Are We Ready For a Growing Area of Intact Protein Analysis?
10.56530/lcgc.na.ci1888f7 · 2022
Sample preparation and fractionation techniques for intact proteins for mass spectrometric analysis
10.1002/jssc.202000936 · 2021
Separation techniques for intact antibody analysis by mass spectrometry
10.1080/10826076.2023.2199328 · 2022
Intact protein bioanalysis by liquid chromatography - High-resolution mass spectrometry
10.1016/j.jchromb.2019.01.032 · 2019
New trends in reversed-phase liquid chromatographic separations of therapeutic peptides and proteins: theory and applications
10.1016/j.jpba.2012.03.024 · 2012
Current and future trends in reversed-phase liquid chromatography-mass spectrometry of therapeutic proteins
10.1016/j.trac.2020.115962 · 2020
Safer solvent blends for food, dye, and environmental analyses using reversed-phase high performance liquid chromatography
10.1007/s10337-021-04061-8 · 2021
A Solvent Dries Up
10.1021/cen-v086n047.p027 · 2008
Bioanalytical solutions to acetonitrile shortages
10.4155/bio.10.76 · 2010
Validated green high-performance liquid chromatographic methods for the determination of coformulated pharmaceuticals: A comparison with reported conventional methods
10.1002/jssc.201401151 · 2015
LC-MS/MS analysis of peptides with methanol as organic modifier: improved limits of detection
10.1021/ac0493368 · 2004
Solvent effect on the detection of peptides and proteins by nanoelectrospray ionization mass spectrometry: anomalous behavior of aqueous 2-propanol
10.1016/j.ab.2024.115461 · 2024
Greening reversed-phase liquid chromatography methods using alternative solvents for pharmaceutical analysis
2018
Adsorption characteristics in reversed-phase liquid chromatography using ethanol water mixed solvent
10.1023/a:1026477619947 · 1999
The toxicity of methanol
10.1016/0024-3205(91)90504-5 · 1991
Acetone as a greener alternative to acetonitrile in liquid chromatographic fingerprinting
10.1002/jssc.201401324 · 2015
Dimethyl carbonate as a green alternative to acetonitrile in reversed-phase liquid chromatography. Part I: Separation of small molecules
10.1016/j.chroma.2023.464477 · 2023
Replacement of acetonitrile by ethanol as solvent in reversed phase chromatography of biomolecules
10.1016/j.jchromb.2010.01.029 · 2010
Assessment of acetone as an alternative to acetonitrile in peptide analysis by liquid chromatography/mass spectrometry
10.1002/rcm.4122 · 2009
Acetonitrile shortage: use of isopropanol as an alternative elution system for ultra/high performance liquid chromatography
10.1039/c0ay00493f · 2011
Solvent selectivity and strength in reversed-phase liquid chromatography separation of peptides
10.1016/j.chroma.2014.02.048 · 2014
AGREE—analytical greenness metric approach and software
10.1021/acs.analchem.0c01887 · doi-reference
Effect of sludge age on the bacterial diversity of bench scale sequencing batch reactors
10.1021/es8026488 · doi-reference
Tracing the limits of organic micropollutant removal in biological wastewater treatment
10.1016/j.watres.2016.03.009 · doi-reference
Early assessment of biodegradability of small molecules to support the chemical design in agro & pharma R&D
10.2533/chimia.2023.742 · doi-reference
Design of a complete ethyl acetate reactive distillation system
10.1252/jcej.36.1352 · doi-reference
Scoring of solvents used in analytical laboratories by their toxicological and exposure hazards
10.1016/j.ecoenv.2015.05.043 · doi-reference
Sustainable and eco-friendly alternatives for liquid chromatographic analysis
10.1021/acssuschemeng.7b01012 · doi-reference
Green chemistry: Science and politics of change
10.1126/science.297.5582.807 · doi-reference
10.1016/j.eiar.2004.06.006
10.1016/j.eiar.2004.06.006 · doi-reference
Multiple solvent elution, a method to counter the effects of coelution and ion suppression in LC-MS analysis in bottom up proteomics
10.1016/j.jchromb.2019.06.017 · doi-reference
Simple approach for improved LC-MS analysis of protein biopharmaceuticals via modification of desolvation gas
10.1021/acs.analchem.8b05846 · doi-reference
Quantitation of total PFAS including trifluoroacetic acid with fluorine nuclear magnetic resonance spectroscopy
10.1021/acs.analchem.2c05354 · doi-reference
Development of a generic reversed-phase liquid chromatography method for protein quantification using analytical quality-by-design principles
10.1016/j.jpba.2020.113412 · doi-reference
Effect of difluoroacetic acid and biological matrices on the development of a liquid chromatography-triple quadrupole mass spectrometry method for determination of intact growth factor proteins
10.1002/jssc.201901254 · doi-reference
High sensitivity LC-MS profiling of antibody-drug conjugates with difluoroacetic acid ion pairing
10.1080/19420862.2019.1658492 · doi-reference
Application of partially fluorinated carboxylic acids as ion-pairing reagents in LC/ESI-MS
10.1016/j.talanta.2014.03.060 · doi-reference
Enhanced sensitivity for peptide mapping with electrospray liquid chromatography-mass spectrometry in the presence of signal suppression due to trifluoroacetic acid-containing mobile phases
10.1016/0021-9673(95)00175-m · doi-reference
Protocols for the analytical characterization of therapeutic monoclonal antibodies. III - Denaturing chromatographic techniques hyphenated to mass spectrometry
10.1016/j.jchromb.2018.08.013 · doi-reference
Ultra-Short-Chain PFASs in the Sources of German Drinking Water: Prevalent, Overlooked, Difficult to Remove, and Unregulated
10.1021/acs.est.1c07949 · doi-reference
Environmental occurrence and biotic concentrations of ultrashort-chain perfluoroalkyl acids: overlooked global organofluorine contaminants
10.1021/acs.est.4c04453 · doi-reference
The global threat from the irreversible accumulation of trifluoroacetic acid (TFA)
10.1021/acs.est.4c06189 · doi-reference
Systematic evaluation of mobile phase additives for the LC-MS characterization of therapeutic proteins
10.1016/j.talanta.2014.12.006 · doi-reference
The effect of the mobile phase additives on sensitivity in the analysis of peptides and proteins by high-performance liquid chromatography-electrospray mass spectrometry
10.1016/j.jchromb.2005.03.041 · doi-reference
Alternative mobile phase additives for the characterization of protein biopharmaceuticals in liquid chromatography e Mass spectrometry
10.1016/j.aca.2021.338347 · doi-reference
Evaluation of strategies for overcoming trifluoroacetic acid ionization suppression resulted in single-column intact level, middle-up, and bottom-up reversed-phase LC-MS analyses of antibody biopharmaceuticals
10.1016/j.talanta.2021.122512 · doi-reference
Perspectives on the replacement of harmful organic solvents in analytical methodologies: a framework toward the implementation of a generation of eco-friendly alternatives
10.1039/c5gc00611b · doi-reference
Greening separation and purification of proteins and peptides
10.1002/jssc.202400554 · doi-reference
Alcohol-based solvents as mobile phases for LC-MS characterization of therapeutic proteins
10.1016/j.jpba.2025.116879 · doi-reference